AstraZeneca gets two more EU drug approvals
14th Dec 2020 07:38
(Sharecast News) - AstraZeneca announced on Monday that 'Trixeo Aerosphere', or formoterol fumarate, glycopyrronium bromide and budesonide, has received approval in the European Union (EU).
Read moreAstraZeneca to buy US drug maker Alexion in $39bn deal
14th Dec 2020 07:01
(Sharecast News) - Pharmaceutical company AstraZeneca said it was buying US drug developer Alexion in a cash and shares deal worth $39bn.
Read moreSunday newspaper round-up: Brexit, Coronavirus, AstraZeneca
13th Dec 2020 18:57
(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian
Read moreAstraZeneca to explore combination of Covid vaccine with Russian jab
11th Dec 2020 11:43
(Sharecast News) - AstraZeneca was set to start testing a combination of its prospective Covid-19 vaccine and Russia's 'Sputnik V' shot, it was reported on Friday, in a bid to strengthen the efficacy of its vaccine developed in conjunction with Oxford University.
Read moreAstraZeneca sells cholesterol drug rights for up to $350m
1st Dec 2020 07:41
(Sharecast News) - AstraZeneca said it had agreed to sell the rights to its cholesterol treatment Crestor to Germany's Grunenthal for up to $350m (£261m).
Read moreAstraZeneca's 'Forxiga' gets approval in Japan for heart failure
30th Nov 2020 07:43
(Sharecast News) - AstraZeneca announced on Monday that 'Forxiga', or dapagliflozin, has been approved in Japan for the treatment of patients with chronic heart failure, who are receiving standard-of-care.
Read moreFriday broker round-up
27th Nov 2020 13:18
(Sharecast News) - GoCo: Deutsche Bank downgrades to hold with a target price of 1,974p.
Read moreEurope close: Stocks give back early gains
23rd Nov 2020 17:23
(Sharecast News) - European shares pared early gains on Monday even after positive news around AstraZeneca's Covid-19 vaccine.
Read moreProof of Covid-19 vaccination may be required for travel, says Qantas
23rd Nov 2020 14:05
(Sharecast News) - International passengers will only be able to travel on Qantas flights if they have been vaccinated against Covid-19, the airline's chief executive has suggested.
Read moreMonday broker round-up
23rd Nov 2020 13:28
(Sharecast News) - DWF Group: Liberum initiates at hold with a target price of 90p.
Read moreAstraZeneca Covid-19 vaccine proves effective
23rd Nov 2020 07:02
(Sharecast News) - AstraZeneca said its Covid-19 vaccine was highly effective in preventing the virus and that it would move quickly to get approval for use.
Read moreUnions call for frontline workers to have priority access to Covid-19 vaccine
20th Nov 2020 08:22
(Sharecast News) - UK unions called for key frontline workers to be given priority access for a Covid-19 vaccine once its rolled out after they were omitted from the list.
Read moreAstraZeneca gets US approval for additional Imfinzi dosing option
20th Nov 2020 07:33
(Sharecast News) - AstraZeneca announced on Friday that 'Imfinzi', or durvalumab, has been approved in the US for an additional dosing option - a 1,500mg fixed dose every four weeks in the approved indications of unresectable stage-3 non-small cell lung cancer after chemoradiation therapy, and previously-treated advanced bladder cancer.
Read moreBerenberg stays at 'buy' on AstraZeneca, positive on antibody treatment
19th Nov 2020 11:10
(Sharecast News) - Analysts at Berenberg struck a positive note on AstraZeneca shares after the drugmaker published full immunogenicity data earlier in the session for its Covid-19 vaccine candidate, AZD 1222.
Read moreAstraZeneca vaccine shows promise among elderly
19th Nov 2020 09:13
(Sharecast News) - AstraZeneca's potential Covid-19 vaccine showed a strong immune response in older people, suggesting it may protect some of those most susceptible to the virus, trial data showed.
Read more